Saturday, July 11, 2026

Patent directory · USPTO A61K / A61P

Patents matching “GlycoDesign Holdings Ltd.”

5 pharma patents match "GlycoDesign Holdings Ltd." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 5
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 5 pharmaceutical patents matching "GlycoDesign Holdings Ltd." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

5 results for “GlycoDesign Holdings Ltd.” · 30,257 patents in full index Clear search

  1. US 6897052

    N-acetylglycosaminyl transferase genes

    GlycoDesign Holdings Ltd. · Granted May 24, 2005 · Expires May 19, 2025

    expired
  2. US 6593119

    Core 2 &bgr;-1,6-N-acetylglycosaminyltransferase gene

    GlycoDesign Holdings Ltd. · Granted Jul 15, 2003 · Expires Jul 10, 2023

    expired
  3. US 6395745

    Alkaloid halide salts of swainsonine and methods of use

    GlycoDesign Holdings Ltd. · Granted May 28, 2002 · Expires May 23, 2022

    expired
  4. US 6051711

    Synthesis of swainsonine salts

    GlycoDesign Holdings Ltd. · Granted Apr 18, 2000 · Expires Apr 13, 2020

    expired
  5. US 6048870

    3, 5, and/or 6 substituted analogues of swainsonine processes for their preparation and their use as therapeutic agents

    GlycoDesign Holdings Ltd. · Granted Apr 11, 2000 · Expires Apr 6, 2020

    expired